Gonorrhea vaccine to be rolled out in the UK

“Up to 40% effective”—are they just trolling us now?

This will be a short post, but check out the following news out of the UK regarding an underwhelmingly effective vaccine against gonorrhea— a “first in the world!” vaccine. What could go wrong? This vaccine rollout will prioritize gay men, of course. This community is certainly in the crosshairs of the pharmaceutical industry, which is unfortunate to say the least.

Here’s the synopsis:

NHS and local government to roll out world-first vaccine programme to prevent gonorrhoea

The pull quote says “Thousands of gonorrhoea cases could be prevented over the next decade thanks to the NHS’ world-first vaccination programme against the infection.” I love these numbers that come from models that only do what you tell them to. (I also love the British spelling of “gonorrhea.”) However, if you read on you will see the following:

People who receive the jab – an existing vaccine for meningococcal B disease, 4CMenB – could be protected from gonorrhoea by up to 40% and help tackle the increasing levels of antibiotic resistant strains of the disease, according to UK Health Security Agency (UKHSA) research. UKHSA is supporting NHS England with the programme’s rollout.

There is a lot here, so let’s unpack it. First of all, notice that once again, we are repurposing old medications—this isn’t new, the notorious AZT famously began its life as a (eventually failed) cancer chemotherapeutic only to be resurrected as a disastrously toxic “anti HIV” drug. I’m really curious to know what made the researchers involved think to use a vaccine for meningitis against gonorrhea, of all things.

But it’s even worse than that—efficacy is up to 40%? Sign me up—not.

We also have this, which is concerning:

Eligible patients, which includes gay and bisexual men who have a recent history of multiple sexual partners or a sexually transmitted infection (STI), will start to be offered the vaccine through local authority-commissioned sexual health services from early August.

It comes after the government accepted the Joint Committee on Vaccination and Immunisation’s (JCVI) advice for an NHS roll out of the vaccine amid a record high 85,000 gonorrhoea diagnoses in England in 2023 – 3 times higher than in 2012.

This reminds me of the stratified rollout of Covid vaccines. But it’s super suspicious—why is this being offered to gay and bisexual men first? After all, gonorrhea, unlike “HIV,” does behave like an STI and affects heterosexuals significantly as well.

Is this yet another attempt to retain the gay community in care? This is so, so creepy when you put the pieces together.

Analysis led by Imperial College London has suggested the vaccine known as 4CMenB could avert up to 100,000 cases of gonorrhoea and save the NHS over £7.9 million over the next decade, if high uptake is achieved and an ongoing programme is confirmed.

Remember what else came out of the Imperial College of London? Neil Ferguson’s ridiculous Covid models that predicted an insanely high number of deaths due to COVID.

The rest of the article is literally just quotes from various physicians endorsing this wonderful vaccine that is 60% likely not to even work. I swear to God, sometimes I think they’re trolling us intentionally because this is bananas. It’s also interesting to note that there is zero mention of any adverse effects that occurred after vaccination.

I’m curious to see how this plays out in the UK and if other countries begin to follow suit. I didn’t realize a vaccine for gonorrhea was even on the radar; I wonder if they’re doing this for other STIs as well. The amount of vaccines the powers that be want us to take is just ridiculous.